Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ¥193,732.87, with a 24-hour trading volume of ¥21.92B. The asset's market cap is ¥173.6T, after moving -0.62% in the last day.
Tokenized Eli Lilly And Co is trading at ¥197,693.34, with a tokenized market cap of ¥7.71B and a 24-hour trading volume of ¥382.04M. The tokenized asset has moved -0.80% in the past 24 hours.